PTCH1 Gene Variants, mRNA Expression, and Bioinformatics Insights in Mexican Cutaneous Squamous Cell Carcinoma Patients
- PMID: 38534460
- PMCID: PMC10968426
- DOI: 10.3390/biology13030191
PTCH1 Gene Variants, mRNA Expression, and Bioinformatics Insights in Mexican Cutaneous Squamous Cell Carcinoma Patients
Abstract
Background: Skin cancer is one of the most frequent types of cancer, and cutaneous squamous cell carcinoma (cSCC) constitutes 20% of non-melanoma skin cancer (NMSC) cases. PTCH1, a tumor suppressor gene involved in the Sonic hedgehog signaling pathway, plays a crucial role in neoplastic processes.
Methods: An analytical cross-sectional study, encompassing 211 cSCC patients and 290 individuals in a control group (CG), was performed. A subgroup of samples was considered for the relative expression analysis, and the results were obtained using quantitative real-time PCR (qPCR) with TaqMan® probes. The functional, splicing, and disease-causing effects of the proposed variants were explored via bioinformatics.
Results: cSCC was predominant in men, especially in sun-exposed areas such as the head and neck. No statistically significant differences were found regarding the rs357564, rs2236405, rs2297086, and rs41313327 variants of PTCH1, or in the risk of cSCC, nor in the mRNA expression between the cSCC group and CG. A functional effect of rs357564 and a disease-causing relation to rs41313327 was identified.
Conclusion: The proposed variants were not associated with cSCC risk in this Mexican population, but we recognize the need for analyzing larger population groups to elucidate the disease-causing role of rare variants.
Keywords: PTCH1; bioinformatics; cutaneous squamous cell carcinoma; genetic variants; mRNA; non-melanoma skin cancer; skin cancer.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico.J Clin Lab Anal. 2024 Feb;38(3):e25010. doi: 10.1002/jcla.25010. Epub 2024 Jan 29. J Clin Lab Anal. 2024. PMID: 38287479 Free PMC article.
-
Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol. 2016 May;130(S2):S125-S132. doi: 10.1017/S0022215116000554. J Laryngol Otol. 2016. PMID: 27841126 Free PMC article.
-
From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.J Transl Med. 2022 Sep 9;20(1):416. doi: 10.1186/s12967-022-03622-1. J Transl Med. 2022. PMID: 36085041 Free PMC article.
-
Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?Br J Dermatol. 2019 Dec;181(6):1146-1155. doi: 10.1111/bjd.17917. Epub 2019 Jul 7. Br J Dermatol. 2019. PMID: 30908599 Free PMC article. Review.
-
New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.Cell Tissue Res. 2016 Sep;365(3):691-702. doi: 10.1007/s00441-016-2457-z. Epub 2016 Jul 14. Cell Tissue Res. 2016. PMID: 27411692 Review.
Cited by
-
A Case of Squamous Cell Carcinoma Arising in Disseminated Superficial Porokeratosis.Clin Cosmet Investig Dermatol. 2024 May 29;17:1259-1263. doi: 10.2147/CCID.S463569. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38827628 Free PMC article.
References
-
- Zavdy O., Coreanu T., Bar-On D.Y., Ritter A., Bachar G., Shpitzer T., Kurman N., Mansour M., Ad-El D., Rozovski U., et al. Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients—A Comparison between Different Immunomodulating Conditions. Cancers. 2023;15:1764. doi: 10.3390/cancers15061764. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources